Subscribe To
Carnival stock looks scary as analyst hits the panic button
Miami-headquartered cruise operator Carnival (NYSE: CCL ) recently received some positive news as the Centers for Disease Control and Prevention ( CD...
July 28, 2022, 7:43 pm
Mastercard earnings top expectations amid ‘robust' spending
Mastercard Inc. became the latest payments company to signal upbeat spending trends as the card giant posted a sizable earnings beat and said it had <...
July 28, 2022, 8:14 am
Pathward financial, inc. (cash) ceo brett pharr on q3 2022 results - earnings call transcript
Start Time: 17:00 January 1, 0000 5:33 PM ET Pathward Financial, Inc. (NASDAQ:CASH ) Q3 2022 Earnings Conference Call July 27, 2022, 17:00 PM ET Compa...
July 27, 2022, 9:58 pm
How a systematic active approach can pinpoint opportunities in emerging markets
Dimensional has applied a systematic yet flexible approach in its emerging markets strategies for nearl...
July 27, 2022, 9:06 pm
Teradyne (ter) q2 earnings top estimates, revenues fall y/y
Teradyne's (TER) second-quarter 2022 results reflect weak demand for mobility and compute-related products. Yet, strong demand for automotive and memo...
July 27, 2022, 2:45 pm
Google is a buy despite disappointing quarterly results
This quarter's less-than-stellar results are not yet a threat to Alphabet's valuation. The cloud contin...
July 27, 2022, 12:08 pm
Microsoft fy 2023 outlook signals growth 'azure'd'
Microsoft's F4Q revenue and earnings miss amplifies how even the biggest and most resilient business cannot fully escape from the grip of a global eco...
July 27, 2022, 11:22 am
7 cybersecurity stocks to buy on the dip
Cybersecurity stocks to buy on the dip is our topic for today. Shares of most cybersecurity firms outperformed the broader market early in 2022 follow...
July 27, 2022, 10:28 am
Google's post-earnings rally signals the bottom is in
Google reported a revenue and earnings miss for Q2, underscoring its vulnerability to broad-based macro challenges. Yet, the stock rallied 5% in post-...
July 27, 2022, 9:50 am
Pharma stocks, etfs can deal with drug pricing legislation
This is a mid-term election year, meaning that some familiar issues investors should be aware of are popping up ...
July 27, 2022, 8:49 am
Airbus delivery target is unrealistic after yet another disappointment
Airbus has strong order momentum. There are indications that this momentum will only improve....
July 27, 2022, 5:28 am
Crude oil price forecast – crude oil markets give up early gains
Crude oil markets rallied significantly during the early hours on Monday but then fell yet again as we ...
July 26, 2022, 11:52 am
Why snap's pain may not be over yet
Snap Inc. continues to be in Wall Street's doghouse, fetching another downgrade over the weekend to add to the pile it amassed late last week....
July 25, 2022, 6:26 pm
Innovation drives profits at paycom
Paycom Software Inc. ( PAYC , Financial) has driven up its earnings per share through innovation—although the share price does not ...
July 25, 2022, 5:07 pm
Bearish gold miner etf jumps over 100% as dollar continues dominance
Even with a potential recession on the horizon, it's not pushing investors into safe-haven assets like gold just yet. The mighty dollar continues its ...
July 25, 2022, 10:22 am
Nutrien: don't add now as its growth could peak in 2022
Nutrien has benefited from the demand/supply imbalance impacting the fertilizer markets, particularly in Potash. However, NTR lost all its post-confli...
July 24, 2022, 10:50 am
The three most important words for roblox investors
Don't log off from this stock just yet....
July 24, 2022, 8:14 am
Smartsheet: the best deal in the software sector
Shares of Smartsheet have fallen 60% this year, despite strong fundamental performance. Revenue growth has continued at a >40% y/y pace. The company h...
July 23, 2022, 9:15 am
This might be the best time yet to buy a used peloton bike
Sale listings for Peloton bikes are proliferating on marketplaces like Craigslist, eBay, and Facebook. "I just want it gone," said one seller....
July 23, 2022, 7:35 am
Albireo: the commercialization of bylvay is the key to a fair valuation
Albireo promotes international sales of its approved product Bylvay for the treatment of the extremely rare and orphan disease PFIC. Investors do not ...
July 22, 2022, 3:50 pm